MedTech Europe’s mission is to make innovative medical technology available to more people, while helping healthcare systems move towards a sustainable path. MedTech Europe encourages policies that help the medical technology industry meet Europe’s growing healthcare needs and expectations. The association also promotes medical technology’s value for Europe focusing on innovation and stakeholder relations, using economic research and data, communications, industry events and training sessions.
MedTech Europe started as an alliance in October 2012 formed by two organizations – EDMA, representing the European in vitro diagnostic industry; and Eucomed, representing the European medical devices industry.
Members of MedTech Europe approved a new Code of Ethical Business Practice in December 2015 to set high ethical standards for the medical technology industry across Europe. The MedTech Europe Code of Ethical Business Practice (the Code) regulates all aspects of the industry’s relationship with Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs), such as hospitals and clinics, including company-organized events, arrangements with consultants, research and financial support to medical education, amongst others. It also introduces an independent enforcement mechanism.
The Code aims at ensuring that all interactions between companies and HCPs and HCOs are ethical and professional at all times, and beyond criticism to maintain the trust of regulators and, most importantly, patients. MedTech Europe is committed to promoting legitimate and ethical business practices and encouraging responsible and ethical interactions with HCPs and HCOs.
Without reservation, Wright strongly endorses both the letter and spirit of the Code.
MedTech Europe Code of Ethical Business Practice